Johnson & Johnson

67,801

$142.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-0.08%) Today
+$0.56 (+0.39%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees
132,200
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
375.09B
Price-Earnings Ratio
22.22
Dividend Yield
2.71
Average Volume
6.52M
High Today
$142.87
Low Today
$141.43
Open Price
$142.87
Volume
4.28M
52 Week High
$157.00
52 Week Low
$109.16

Collections

Digestible Financial News

Jack Kramer & Nick Martell

Managing Editors of News & Snacks at Robinhood Financial LLC

JNJ News

ReutersJul 9

Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally

Bottles of Johnson's baby powder are displayed in a store in New York By Carl O'Donnell (Reuters) - More than 170 nonprofit groups on Wednesday called for Joh
0
ReutersJul 8

Potential COVID-19 vaccine not 'single solution' to pandemic, Johnson & Johnson CEO says

FILE PHOTO: Alex Gorsky, chairman and CEO of Johnson & Johnson, takes the stand as a witness in New Jersey Supreme Court in New Brunswick, New Jersey, U.S., Jan
0
ReutersJul 8

J&J's Cilag to sell up to 11.8 million Idorsia shares

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo ZURICH (Reuters) - Johnson & Joh
0

JNJ Earnings

$0.00
$0.86
$1.72
$2.58
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
$1.47 per share
Actual
Available Jul 16, Pre-Market

You May Also Like

More JNJ News

ReutersJul 6

Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo (Reuters) - Johnson & Johnson (J
0
ReutersJul 6

Catalent plant in Italy will help produce J&J's potential COVID-19 vaccine - minister

ROME, July 6 (Reuters) - A plant in Italy owned by U.S. group Catalent will help produce the potential COVID-19 vaccine being developed by drugmaker Johnson & J
0
MarketWatchJul 6

Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J

Shares of Emergent BioSolutions Inc. EBS, +2.64% were up 1.1% in premarket trading on Monday after it announced a five-year deal with Johnson & Johnson JNJ, +0.
0
ReutersJul 6

Emergent signs five-year deal backing J&J COVID-19 vaccine

FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration t
0
ReutersJul 6

BRIEF-Emergent Biosolutions Says Will Begin Providing Large-Scale Drug Substance Manufacturing For Johnson & Johnson's Adenovirus-Based Covid-19 Vaccine In 2021

July 6 (Reuters) - Emergent BioSolutions Inc: * EMERGENT BIOSOLUTIONS SIGNS FIVE-YEAR AGREEMENT FOR LARGE-SCALE DRUG SUBSTANCE MANUFACTURING FOR JOHNSON & JOHN
0
ReutersJul 6

Emergent to make drug substance for J&J's COVID-19 vaccine candidate

FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration
0
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.